A comprehensive analysis of renal cell carcinoma as first and second primary cancers
- PMID: 35220978
- PMCID: PMC8883617
- DOI: 10.1186/s12957-022-02493-6
A comprehensive analysis of renal cell carcinoma as first and second primary cancers
Abstract
Objective: Second primary renal cell carcinoma (2nd RCC) refers to renal cell carcinoma (RCC) diagnosed after another unrelated malignancy. This study aims to compare the clinical manifestation, pathology, treatment, and prognostic features of patients with 2nd RCC and first primary renal cell carcinoma (1st RCC).
Materials and methods: Data of the patients with localized RCC were retrospectively collected. They were classified as 2nd RCC or 1st RCC according to a previously diagnosed cancer, including 113 cases of 2nd RCC and 749 cases of 1st RCC.
Results: The most common types of extrarenal malignancies in patients with 2nd RCC include lung, colorectal, breast, gynecological, and gastric cancers. The age and smoking rate of 2nd RCC patients were significantly higher than in those of 1st RCC patients. For 2nd RCC patients, fewer had clinical symptoms and renal masses tend to be smaller. One hundred and eight (95.6%) patients with 2nd RCC received surgical interventions. All patients with 1st RCC underwent renal surgery. More patients with 2nd RCC underwent a partial nephrectomy. Pathologically, there was no significant difference in postoperative pathological types between the 2nd and 1st RCCs. However, the 2nd RCCs were commonly identified in the early stages. The median overall survival (OS) of 2nd RCC patients was 117 months, which was shorter than that of 1st RCC patients.
Conclusions: Second RCC is not uncommon. More attention should be paid to screening for 2nd RCC in cancer survivors. There are some differences between patients with 2nd and 1st RCCs that should be viewed separately.
Keywords: Comparison; Multiple primary malignancy; Renal cell carcinoma; Second primary cancers.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Evaluation of functional outcome of bilateral kidney tumors after sequential surgery.BMC Cancer. 2021 May 24;21(1):592. doi: 10.1186/s12885-021-08324-3. BMC Cancer. 2021. PMID: 34024273 Free PMC article.
-
The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy.Eur Urol Oncol. 2020 Feb;3(1):47-56. doi: 10.1016/j.euo.2019.10.002. Epub 2019 Nov 14. Eur Urol Oncol. 2020. PMID: 31735646 Free PMC article.
-
The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.Eur Urol. 2008 Oct;54(4):855-63. doi: 10.1016/j.eururo.2008.04.079. Epub 2008 May 9. Eur Urol. 2008. PMID: 18487007
-
Management of renal masses in transplant allografts at an Australian kidney-pancreas transplant unit.Transplantation. 2014 Mar 27;97(6):654-9. doi: 10.1097/01.TP.0000437333.38786.fd. Transplantation. 2014. PMID: 24212503 Review.
-
Paraneoplastic Glomerulonephropathy Associated With Renal Cell Carcinoma: A Descriptive Analysis of Published Reports.Cureus. 2023 Mar 30;15(3):e36928. doi: 10.7759/cureus.36928. eCollection 2023 Mar. Cureus. 2023. PMID: 37131574 Free PMC article. Review.
Cited by
-
Altered NCR3 Splice Variants May Result in Deficient NK Cell Function in Renal Cell Carcinoma Patients.In Vivo. 2024 Jan-Feb;38(1):174-183. doi: 10.21873/invivo.13423. In Vivo. 2024. PMID: 38148073 Free PMC article.
-
Clinical and survival differences between second primary and first primary nasopharyngeal carcinoma in a retrospective study.Discov Oncol. 2025 Aug 12;16(1):1538. doi: 10.1007/s12672-025-03250-3. Discov Oncol. 2025. PMID: 40794343 Free PMC article.
-
TET1 methylation and mRNA expression in renal cell carcinoma: implications for tumor staging and prognosis.Eur J Med Res. 2025 Aug 20;30(1):778. doi: 10.1186/s40001-025-03051-y. Eur J Med Res. 2025. PMID: 40830820 Free PMC article.
-
A Rare Case of Concurrent Chromophobe Renal Cell Cancer with Lung Neuroendocrine Tumor: A Case Report and Literature Review.Ann Med Surg (Lond). 2024 Feb 19;86(4):2230-2235. doi: 10.1097/MS9.0000000000001841. eCollection 2024 Apr. Ann Med Surg (Lond). 2024. PMID: 38576925 Free PMC article.
References
-
- Liu H, Hemminki K, Sundquist J, Holleczek B, Katalinic A, Emrich K, Jansen L, Brenner H. GEKID Cancer Survival Working Group. A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects. Cancer Med. 2013;2(5):718–724. doi: 10.1002/cam4.116. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical